ORIC Long Put Strategy
ORIC (ORIC Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an allosteric inhibitor targeting the polycomb repressive complex 2, specifically for the treatment of prostate cancer. Furthermore, ORIC-114 is a brain-penetrant, orally administered, irreversible inhibitor crafted to precisely target epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), demonstrating high potency against exon 20 insertion mutations. Beyond these advanced programs, ORIC Pharmaceuticals is also cultivating multiple early-stage precision medicines aimed at other mechanisms of cancer resistance.
ORIC (ORIC Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $814.7M, a beta of 0.98 versus the broader market, a 52-week range of 7.23-14.68, average daily share volume of 1.6M, a public-listing history dating back to 2020, approximately 111 full-time employees. These structural characteristics shape how ORIC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.98 places ORIC roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long put on ORIC?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
ORIC snapshot
As of November 13, 2026, spot at $7.92. The long put on ORIC below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on ORIC specifically: IV rank is unavailable in the current snapshot, so regime-based timing for ORIC is inferred from ATM IV alone. The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORIC expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORIC should anchor to the underlying notional of $7.92 per share and to the trader's directional view on ORIC stock.
ORIC long put setup
The ORIC long put below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORIC at $7.92 on that close, the first option leg uses a $8.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORIC chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORIC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $8.00 | $3.02 |
ORIC long put risk and reward
- Net Premium / Debit
- -$302.00
- Max Profit (per contract)
- $497.00
- Max Loss (per contract)
- -$302.00
- Breakeven(s)
- $4.98
- Risk / Reward Ratio
- 1.646
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
ORIC long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on ORIC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | +$497.00 |
| $1.76 | -77.8% | +$321.99 |
| $3.51 | -55.7% | +$146.99 |
| $5.26 | -33.6% | -$28.02 |
| $7.01 | -11.5% | -$203.02 |
| $8.76 | +10.6% | -$302.00 |
| $10.51 | +32.7% | -$302.00 |
| $12.26 | +54.8% | -$302.00 |
| $14.01 | +76.9% | -$302.00 |
| $15.76 | +99.0% | -$302.00 |
When traders use long put on ORIC
Long puts on ORIC hedge an existing long ORIC stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ORIC exposure being hedged.
ORIC thesis for this long put
A ORIC long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long ORIC position with one put per 100 shares held. As a Healthcare name, ORIC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORIC-specific events.
ORIC long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORIC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORIC alongside the broader basket even when ORIC-specific fundamentals are unchanged. Long-premium structures like a long put on ORIC are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ORIC chain quotes before placing a trade.
Frequently asked questions
- What is a long put on ORIC?
- A long put on ORIC is the long put strategy applied to ORIC (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With ORIC stock at $7.92 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed ORIC chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ORIC long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the ORIC long put priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV the current ATM IV), the computed maximum profit is $497.00 per contract and the computed maximum loss is -$302.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORIC long put?
- The breakeven for the ORIC long put priced on this page is roughly $4.98 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk.
- When should you consider a long put on ORIC?
- Long puts on ORIC hedge an existing long ORIC stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ORIC exposure being hedged.
- How does current ORIC implied volatility affect this long put?
- Current ORIC ATM IV is the current ATM IV; IV rank context is unavailable in the current snapshot.